MoonLake Immunotherapeutics (Non-dilutive financing)
Funding Details
- Awarder
- Inbox
- Date Award
- May 17, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $500,000,000
Company Info
- Founding Year
- 2021
- Traction
- MoonLake is progressing eight Phase 2 and Phase 3 clinical trials and will hold a Capital Markets Update to discuss the Hercules partnership and provide important clinical updates.
- Company Description
- MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.
- Market
- Inflammatory diseases
- Location
- Zug, Switzerland
- Coinvestors
- Hercules Capital, Inc.